PYC Therapeutics Invited to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

SAN DIEGO and PERTH, Australia: SAN DIEGO and PERTH, Australia, Sept. 15, 2021 /PRNewswire/ — PYC Therapeutics (ASX: PYC), a biotechnology company combining two complementary platform technologies (selective drug delivery and precision drug design) to develop a new generation of RNA therapeutics to change the lives of patients with inherited diseases, today announced it will participate as one of a select group of companies at the upcoming Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, taking place virtually on September 20–23, 2021.
Click here to view original post